Ultra-early rt-PA administration should improve patient outcome on mechanical thrombectomy: Post hoc analysis of SKIP

[1]  K. Toyoda,et al.  Endovascular Therapy for Acute Stroke with a Large Ischemic Region. , 2022, The New England journal of medicine.

[2]  J. Grotta,et al.  Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study. , 2022, JAMA neurology.

[3]  B. Baxter,et al.  Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. , 2022, The New England journal of medicine.

[4]  D. Liebeskind,et al.  Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. , 2022, The New England journal of medicine.

[5]  M. Wiesmann,et al.  Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial , 2022, The Lancet.

[6]  L. Beenen,et al.  A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. , 2021, The New England journal of medicine.

[7]  T. Ueda,et al.  Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. , 2021, JAMA.

[8]  R. Nogueira,et al.  Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. , 2021, JAMA.

[9]  Y. Zhou,et al.  Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke , 2020, New England Journal of Medicine.

[10]  Thalia Shoshana Field,et al.  Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment , 2020, Stroke.

[11]  T. Iwama,et al.  Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society , 2019, Neurologia medico-chirurgica.

[12]  X. Ji,et al.  Asymptomatic Intracerebral Hemorrhage May Worsen Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Thrombectomy. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[13]  Hester F. Lingsma,et al.  Hemorrhagic transformation is associated with poor functional outcome in patients with acute ischemic stroke due to a large vessel occlusion , 2018, Journal of NeuroInterventional Surgery.

[14]  Adnan H Siddiqui,et al.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.

[15]  P. Sandercock,et al.  Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis , 2016, The Lancet Neurology.

[16]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[17]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials , 2014, The Lancet.

[18]  C. Molina,et al.  Impact of Time to Treatment on Tissue-Type Plasminogen Activator–Induced Recanalization in Acute Ischemic Stroke , 2014, Stroke.

[19]  R. Libman,et al.  Is asymptomatic hemorrhagic transformation really innocuous? , 2012, Neurology.

[20]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[21]  K. Kimura,et al.  Early stroke treatment with IV t-PA associated with early recanalization , 2010, Journal of the Neurological Sciences.

[22]  K. Kimura,et al.  Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery , 2008, Journal of the Neurological Sciences.

[23]  D. Hermann,et al.  Tissue plasminogen activator-induced reperfusion injury after stroke revisited. , 2007, Circulation.

[24]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[25]  A. Demchuk,et al.  Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry , 2007, Stroke.

[26]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[27]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.